Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AZN
Recent news which mentions AZN
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
August 10, 2022
Tickers
AZN
ZNTL
Tags
General
ZNTL
Briefs
From
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Tickers
ARCT
AXSM
AYTU
AZN
Tags
Financing
ITCI
MRSN
From
Benzinga
AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients
August 09, 2022
Tickers
AZN
AZNCF
DSKYF
DSNKY
Tags
DSKYF
Briefs
News
From
Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
Tickers
AZN
CINC
ENDP
HCM
Tags
VALN
KOD
KRTX
From
Benzinga
AstraZeneca (AZN) Announces Approval of ENHERTU (HER2-low Metastatic Breast Cancer) in the United States
August 08, 2022
Tickers
AZN
Tags
News
AZN
Analyst Rating
From
Best Stocks
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
Tickers
AZN
MRNA
PFE
VALN
Tags
Health Care
Small Cap
Biotech
From
Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
August 08, 2022
Tickers
AZN
EVO
KTTA
MRK
Tags
EVO
KTTA
General
From
Benzinga
AstraZeneca's Tagrisso Doublet Therapy Shows 49% Response Rate In Lung Cancer Setting
August 08, 2022
Tickers
AZN
AZNCF
HCM
Tags
News
Briefs
General
From
Benzinga
3 Unstoppable Stocks That Don't Care About the Bear Market
August 07, 2022
Tickers
ABBV
AZN
BMY
Tags
Recent Press Releases
BMY
ABBV
From
Motley Fool
Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal
August 05, 2022
Tickers
ABBV
AZN
BMY
JNJ
Tags
JNJ
MRK
LLY
From
MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 04, 2022
Tickers
ARQT
ATXS
AZN
MRK
Tags
Small Cap
AZN
Biotech
From
Benzinga
Pieris Stops Work On Cancer Med, Tested In Combo With Eli Lilly Drugs
August 04, 2022
Tickers
AZN
AZNCF
LLY
PIRS
Tags
General
Earnings
PIRS
From
Benzinga
AstraZeneca and Merck Receives European Commission Approval For Expanded Use In Breast Cancer Therapy
August 04, 2022
Tickers
AZN
MRK
Tags
Health Care
General
Benzinga
From
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Tickers
ABUS
ACAD
ADAP
AGIO
Tags
Earnings
BCRX
NBIX
From
Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
August 02, 2022
Tickers
AZN
EBS
JNJ
Tags
EBS
General
Earnings
From
Benzinga
Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody
August 01, 2022
Tickers
AVTX
AZN
Tags
Health Care
Biotech
AZN
From
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Tickers
ALXO
ARQT
AZN
BEAM
Tags
CYAD
Market News
Penny Stocks
From
Benzinga
AstraZeneca Cuts Innate-Partnered Phase 3 Trial In Head & Neck Cancer
August 01, 2022
Tickers
AZN
AZNCF
IPHA
Tags
IPHA
AZNCF
Market News
From
Benzinga
Do These 3 New Moneymakers for AstraZeneca Make It a Buy?
July 31, 2022
Tickers
AMGN
AZN
Tags
Market News
AZN
Recent Press Releases
From
Motley Fool
3 Stocks We Think Could Beat the Market in the Second Half of 2022
July 30, 2022
Tickers
ABBV
AZN
JNJ
Tags
ABBV
Recent Press Releases
Market News
From
Motley Fool
AstraZeneca Drops Moderna-Partnered, Phase 2 Heart Disease Drug Candidate
July 29, 2022
Tickers
AZN
AZNCF
MRNA
Tags
General
News
Briefs
From
Benzinga
Daily Biotech Pulse: Bausch Health To Appeal Xifaxan Patent Decision, Bristol Myers Drug Combo Fails In Kidney Cancer Trial, Sarepta's Duchenne Candidate Update
July 29, 2022
Tickers
ABBV
ADMP
ARQT
AZN
Tags
RHHBY
Movers
News
From
Benzinga
Recap: AstraZeneca Q2 Earnings
July 29, 2022
Tickers
AZN
Tags
AZN
BZI/Recaps
News
From
Benzinga
Benzinga Before The Bell: Apple's Strong China Revenue, Amazon's EV Partnership, Jack Ma To Cede Control Of Ant Financial And Other Top Financial Stories Friday, July 29
July 29, 2022
Tickers
AAPL
AMZN
AZN
BABA
Tags
AAPL
Penny Stocks
Benzinga
From
Benzinga
AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance
July 29, 2022
Tickers
AZN
AZNCF
Tags
Large Cap
AZN
Biotech
From
Benzinga
Earnings Scheduled For July 29, 2022
July 29, 2022
Tickers
AB
ABBV
ABR
ABTX
Tags
PFS
ABR
GHM
From
Benzinga
$100 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
July 28, 2022
Tickers
AZN
Tags
AZN
News
Earnings
From
Benzinga
FDA Accepts AstraZeneca's Submission For Low Breast Cancer Candidate Under Priority Review
July 25, 2022
Tickers
AZN
Tags
Market News
FDA
Benzinga
From
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Tickers
AZN
DSNKY
ENVB
IBB
Tags
TNXP
PSTI
General
From
Benzinga
U.S. Stock Futures Higher; Crude Oil Rises 1%
July 25, 2022
Tickers
AZN
FRD
PKG
REVB
Tags
Earnings
WHR
Pre/Market Outlook
From
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.